All you need for immuno-oncology B cell research

Live webinar

In this webinar, we will review the role of B cell and therapeutic antibody-based immunotherapies in immuno-oncology research. Susanne Bethke Ph.D., global product manager for B cells, will discuss the following topics:

  • Strategies used to generate therapeutic antibodies
  • Techniques for analyzing antibody repertoires in cancer research
  • Tools offered by Miltenyi Biotec that assist your research and work with B cells

There will be time for questions and discussion after the 45-minute webinar.

 

Sessions (choice of two dates)

September 25, 2019
Berlin, Germany GMT+02:00) – 7:00 PM CET 
New York, USA (GMT-04:00) – 1:00 PM GMT 
San Francisco, USA (GMT-07:00) – 10:00 AM GMT

Register here

September 26, 2019
Berlin, Germany (GMT+02:00) – 10:00 AM CET
London, United Kingdom (GMT+01:00) –  9:00 AM GMT
Singapore, Singapore (GMT+08:00) – 4:00 PM  

Register here

 

About the presenter

Susanne joined Miltenyi Biotec in 2018, after successfully completing her Ph.D. thesis at the RWTH Aachen University. In cooperation with the Fraunhofer IME Aachen, she worked on B cell transformation and antibody isolation targeting malaria-specific antigens. She also gained valuable experience at the University of Cape Town, where she completed her masters project on an HPV vaccine efficacy test system.

Susanne Bethke, Ph.D., Miltenyi Biotec